Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide-conjugated morpholino oligomer

Anantpadma, Manu ; Stein, David A. ; Vrati, Sudhanshu (2010) Inhibition of Japanese encephalitis virus replication in cultured cells and mice by a peptide-conjugated morpholino oligomer Journal of Antimicrobial Chemotherapy, 65 (5). pp. 953-961. ISSN 0305-7453

Full text not available from this repository.

Official URL: http://jac.oxfordjournals.org/content/65/5/953.sho...

Related URL: http://dx.doi.org/10.1093/jac/dkq074

Abstract

Background: Japanese encephalitis virus (JEV) has a significant impact on public health throughout Asia, and there is a pressing need for development of new therapeutics against it. Methods: Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) are antisense agents that enter cells readily and interfere with gene expression. Four PPMOs, targeting various locations in the JEV genome, were evaluated for antiviral activity against JEV in cultured cells and the mouse model of JEV infection. Results: A PPMO (P10882) targeting the JEV 3' cyclization sequence (3CSI) had significant antiviral activity in Vero (epithelial), Neuro2A (neuronal) and J774E (macrophage) cells at concentrations that were not cytotoxic. P10882 added before infection suppressed JEV replication to an undetectable level in Vero cells and produced a 93 and 66 reduction in titre in J774E and Neuro2A cells, respectively, when measured at 24 h post-infection. In uninfected cells, fluorescein-labelled PPMOs entered J774E cells most efficiently, followed by Vero and Neuro2A cells. The antiviral effect of P10882 was also demonstrated in vivo, where 6080 of 1-week-old mice treated intracerebrally with a 20 mg/kg dose of P10882 every 12 h for 5 days were protected from a lethal dose of JEV and showed an undetectable level of virus in brain tissue at 2 days post-infection. Conclusions: P10882, which targets sequence that is highly conserved across members of the JEV serocomplex, was previously shown to be effective in a mouse model of West Nile disease, and represents a candidate antiviral agent against members of the JEV serocomplex.

Item Type:Article
Source:Copyright of this article belongs to Oxford University Press.
Keywords:Antisense; Antiviral; JEV; PPMO; Flavivirus
ID Code:55149
Deposited On:18 Aug 2011 07:49
Last Modified:18 Aug 2011 07:49

Repository Staff Only: item control page